Ir.fractyl.com

  1. Home
  2. Ir.fractyl.com

Fractyl Health Reports First Quarter 2024 Financial Results and

WebInitiation of Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of GLP-1 based drugs expected in the second half of 2024 …

Actived: 1 days ago

URL: https://ir.fractyl.com/news-releases/news-release-details/fractyl-health-reports-first-quarter-2024-financial-results-and

Fractyl Health Receives FDA IDE Approval for the Revita® Remain …

WebRevita aims to be the first approved therapeutic option for durable weight maintenance after discontinuation of GLP-1 based drugs, as an adjunct to diet and …

Category:  Health Go Health

Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial

WebReceived IDE approval for the Revita® Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of GLP-1 Based Drugs …

Category:  Health Go Health

Fractyl Health Announces Publication of Pioneering New Model of

Web-Publication represents paradigm shift in our understanding of metabolism and the gut’s role in obesity and metabolic disease- -We believe the Metabolic Balance …

Category:  Health Go Health

Fractyl Health Announces Multiple Presentations at the Upcoming

WebAt DDG, Fractyl Health will present new clinical updates on its ongoing real-world registry study of Revita ® in patients with T2D in Germany. At DDW, Fractyl Health …

Category:  Health Go Health

Fractyl Health Presents Clinical Update on Revita® German Real …

WebFirst 14 participants with at least six months of follow up continue to demonstrate sustained improvements in blood glucose and weight with reduction in T2D …

Category:  Health Go Health

0001193125-24-017309 S-1/A Fractyl Health, Inc.

WebJan 29, 2024. Document Date. Jan 29, 2024. Form Description. Amended Registration statement for face-amount certificate companies.

Category:  Health Go Health

Fractyl Health Announces Pricing of Initial Public Offering

WebLEXINGTON, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focused on pioneering new approaches for …

Category:  Health Go Health

Fractyl Health to Report First Quarter 2024 Financial Results and

WebBURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new …

Category:  Health Go Health

Fractyl Health Appoints Samuel Conaway to Its Board of Directors

WebLEXINGTON, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (“Fractyl Health” or the “Company”), a metabolic therapeutics company focused …

Category:  Health Go Health

Fractyl Health Announces New Results From Its Rejuva® Platform

WebData provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of …

Category:  Health Go Health

Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific …

WebFractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer. LEXINGTON, Mass.– ( BUSINESS WIRE )– Fractyl Health, a metabolic therapeutics …

Category:  Health Go Health

SEC Filings Fractyl Health, Inc.

WebAnnual report which provides a comprehensive overview of the company for the past year. Annual Filings. View HTML. 0000950170-24-038866.pdf. 0000950170-24 …

Category:  Health Go Health

Fractyl Health Announces Nomination of RJVA-001 as First Clinical

WebRJVA-001 is the first GLP-1 pancreatic gene therapy (GLP1 PGTx) candidate to be nominated by the Company and is designed to improve upon known issues of …

Category:  Health Go Health

News Releases Fractyl Health, Inc.

WebNews Releases. Year. 2024. May 13, 2024. Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates. Read More. May 13, 2024. Fractyl …

Category:  Health Go Health

Fractyl Health Demonstrates Significant Improvement in Glucose …

WebRevolutionary one-time pancreatic gene therapy resulted in up to 54% lower blood glucose and 20% lower total bodyweight than chronic semaglutide 10 nmol/kg/day …

Category:  Health Go Health

Analyst Coverage Fractyl Health, Inc.

WebAnalyst. BofA Securities. Jason Gerberry. Morgan Stanley. Michael Ulz. Evercore ISI. Umer Raffat. Fractyl Health, Inc. is followed by the analysts listed. Please note that any …

Category:  Health Go Health

Fractyl Announces FDA IDE Approval to Begin Pivotal Study of …

WebRevita T2Di pivotal study to evaluate the ability of Revita DMR, the first non-drug, non-surgical, disease-modifying therapy, to eliminate need for insulin injections in …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Bradford mental health counseling

 › Healthy vs unhealthy meals

 › Meritas health neurology north kansas city

 › Al dhaid health center services

 › Al dhaid health center map

 › Film effect on mental health

 › Nj health insurance toms river

 › Health department reno nv

 › Environmental determinants of health

 › Torrence hands health care

Recently Searched

 › The healthy homes program manual

 › Kordinator mhealthcoach net vcl clark county

 › Wheatbelt mental health service gingin

 › Baptist health med towers 2

 › Adventhealth lab test directory

 › Intervention development in public health

 › Florida license lookup mental health

 › Child health clinic aurora co

 › New public health interventions

 › Bcbs ers texas health select